Thrombophilic causes of retinal vascular thrombosis: Etiology and treatment outcomes

Clinical and Applied Thrombosis/Hemostasis

Volumn 8, Issue 4, 2002, Pages 315-318

  Bick, Rodger L ^a   Alfar, Hitaf ^b   Goedecke, Chris ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b ThromboCare Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACTIVATED PROTEIN C; ANTITHROMBIN; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5 LEIDEN; CLOPIDOGREL; DALTEPARIN; PHOSPHOLIPID ANTIBODY; PLASMINOGEN ACTIVATOR INHIBITOR 1; WARFARIN;

ADOLESCENT; ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD CLOTTING FACTOR 5 DEFICIENCY; CLINICAL ARTICLE; DIABETES MELLITUS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HYPERTENSION; MALE; OPEN ANGLE GLAUCOMA; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; QUALITY OF LIFE; RETINA BLOOD VESSEL OCCLUSION; SEX RATIO; THROMBOSIS; TREATMENT OUTCOME; VEIN THROMBOSIS;

EID: 0036819166     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960200800402     Document Type: Article

References (14)

1. Toschi V, Motta A, Castelli C, et al. High prevalence of antiphosphatidylinositol antibodies in young patients with cerebral ischemia of undetermined cause. Stroke 1998;29:1759.
2. Bick RL. Recurrent miscarriage syndrome and infertility caused by blood coagulation protein or platelet defects. Hematol Oncol Clin North Am 2000;14:1117.
3. Bick RL. Antiphospholipid thrombosis syndromes. J Clin Appl Thromb Hemost 2001;7:241.
4. Klein BA, Olwin JH. A survey of the pathogenesis of retinal venous occlusion: Emphasis upon choice of th4erapy and an analysis of the therapeutic results in fifty-three patients. Arch Ophthalmol 56:207, 195.
5. Green BA, Chan CC, Hutchins GM. Central retinal vein occlusion: A prospective histopathologic study of twentynine eyes in 28 cases. Retina 1981;1:27.
6. The Eye Disease Case-Control Study Group: Risk factors for central retinal vein occlusion. Arch Ophthalmol 1996;114:545.
7. Schwab PJ, Okun E, Fahey FJ. Reversal of retinopathy in Waldenstroms macroglobulinemia by plasmapheresis: A report of two cases. Arch Ophthalmol 1960;64:67.
8. Vine AK, Samama MM. The role of abnormalities in the anticoagulant and fibrinolytic systems in retinal vascular occlusions. Surv Ophthalmol 1996;37:200.
9. Khamashta MA, Cuadrado MJ, Mujic F. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995;332:993.
10. Jacobson DM. Systemic cholesterol microembolization syndrome masquerading as giant cell arteritis. Surv Ophthalmol 1991;35:23.
11. Chopdar A. Multiple major retinal vascular occlusions in sickle cell haemoglobin C disease. Br J Ophthalmol 1975;59:493.
12. Stowe GC, Zakov ZN, Albert DM. Central retinal vascular occlusion associated with oral contraceptives. Am J Ophthalmol 1978;86:798.
13. Berg W, Verbraak FD, Bos PJM. Homocystinuria presenting as central retinal artery occlusion and long-standing thromboembolic disease. Br J Ophthalmol 1990;74:696.
14. Walsh PN, Kansu T, Savino PJ. Platelet coagulant activators in arterial occlusive disease of the eye. Stroke 1979;10:589.